The table below shows ADMA BIOLOGICS, INC.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$58.25M
-$19.68M
-$2.22M
-$14.72M
-$26.01M
-$33.23M
Capital expenditure
$2.54M
$4.70M
$2.35M
$1.95M
$2.84M
$2.57M
Investing cash flow
$2.40M
-$4.72M
-$2.36M
-$1.95M
-$2.84M
-$2.57M
Dividends paid
-
-
-
-
ADMA operating cash flow (10-K history)
ADMA BIOLOGICS, INC. reported operating cash flow of $50.40M for fiscal year 2025. That is down 57.5% from $118.67M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$18.27M (FY 2016) to $50.40M. Figures come from the company's audited annual reports as filed with the SEC.